1. Home
  2. NLSP vs BCML Comparison

NLSP vs BCML Comparison

Compare NLSP & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • BCML
  • Stock Information
  • Founded
  • NLSP 2015
  • BCML 2004
  • Country
  • NLSP Switzerland
  • BCML United States
  • Employees
  • NLSP N/A
  • BCML N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • BCML Major Banks
  • Sector
  • NLSP Health Care
  • BCML Finance
  • Exchange
  • NLSP Nasdaq
  • BCML Nasdaq
  • Market Cap
  • NLSP 243.8M
  • BCML 261.8M
  • IPO Year
  • NLSP 2021
  • BCML N/A
  • Fundamental
  • Price
  • NLSP $4.45
  • BCML $24.19
  • Analyst Decision
  • NLSP
  • BCML
  • Analyst Count
  • NLSP 0
  • BCML 0
  • Target Price
  • NLSP N/A
  • BCML N/A
  • AVG Volume (30 Days)
  • NLSP 32.3K
  • BCML 18.6K
  • Earning Date
  • NLSP 10-18-2024
  • BCML 10-21-2024
  • Dividend Yield
  • NLSP N/A
  • BCML 1.66%
  • EPS Growth
  • NLSP N/A
  • BCML N/A
  • EPS
  • NLSP N/A
  • BCML 2.12
  • Revenue
  • NLSP N/A
  • BCML $97,490,000.00
  • Revenue This Year
  • NLSP N/A
  • BCML N/A
  • Revenue Next Year
  • NLSP N/A
  • BCML $3.40
  • P/E Ratio
  • NLSP N/A
  • BCML $11.02
  • Revenue Growth
  • NLSP N/A
  • BCML N/A
  • 52 Week Low
  • NLSP $4.08
  • BCML $18.54
  • 52 Week High
  • NLSP $35.60
  • BCML $25.04
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 36.17
  • BCML 62.23
  • Support Level
  • NLSP $4.72
  • BCML $23.25
  • Resistance Level
  • NLSP $5.36
  • BCML $24.14
  • Average True Range (ATR)
  • NLSP 0.56
  • BCML 0.38
  • MACD
  • NLSP -0.01
  • BCML -0.01
  • Stochastic Oscillator
  • NLSP 19.79
  • BCML 83.97

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.

Share on Social Networks: